Quantamental Technologies LLC Veracyte, Inc. Transaction History

Quantamental Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $181,836 - $355,597	11,877 New	11,877 $281,000
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $58,323 - $111,438	3,775 Added 48.17%	11,612 $231,000
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $171,943 - $333,150	7,837 New	7,837 $216,000
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $214,194 - $319,243	-5,935 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $211,404 - $314,376	5,935 New	5,935 $276,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.